Furlano
Bruce Michael Furlano, Vernon Hills, IL US
Patent application number | Description | Published |
---|---|---|
20130171315 | SWEETENER COMPOSITION - A sweetener composition comprising at least one high intensity sweetener, erythritol, and at least one or more hydrocolloid, and beverage or food compositions containing such a sweetener composition, are disclosed. | 07-04-2013 |
20130267693 | CRYSTALLINE FORMS OF REBAUDIOSIDE B - A process for production of crystalline rebaudioside B from rebaudioside A is described. Additionally, four distinct crystal polymorphic forms of rebaudioside B are described, as well as methods for converting from one crystal polymorphic form of rebaudioside B to another crystal polymorphic form of rebaudioside B. | 10-10-2013 |
David Furlano, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090053329 | COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS - Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown to induce a rapid onset of antipsychotic action and increase the number of responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic. | 02-26-2009 |
20130143901 | COMBINATION OF PIMAVANSERIN AND RISPERIDONE FOR THE TREATMENT OF PSYCHOSIS - Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown to induce a rapid onset of antipsychotic action and increase the number of responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic. | 06-06-2013 |
Stephane Furlano, Izeron FR
Patent application number | Description | Published |
---|---|---|
20130221948 | FUNCTIONAL MEASURING GROUP FOR A MEDIUM-VOLTAGE DISTRIBUTION SUBSTATION - The design of a functional measuring group for a medium-voltage substation has been optimized to make the product compact and robust in terms of internal arc, and also to favour complete accessibility to the measurement sensors. In particular, the voltage sensors are located in a vertical plane directly accessible via the front panel of the group, and the current sensors are located in the rear housing of the group, being directly accessible via the top of the group. In addition to being placed in an insulated compartment, the voltage sensors are insulated and shielded, and their connection terminals are designed for connection by cable with a flat interface. | 08-29-2013 |